id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0125-0007,FDA,FDA-2006-E-0125,Determination of Regulatory Review Period for Purposes of Patent Extension; NAMENDA,Notice,General Notice,2007-06-05T04:00:00Z,2007,6,2007-06-05T04:00:00Z,2007-08-07T03:59:59Z,2026-01-06T19:29:24Z,E7-10730,0,0,09000064804501cc
FDA-2006-E-0125-0006,FDA,FDA-2006-E-0125,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-05-17T04:00:00Z,2007,5,,,2026-01-06T19:23:02Z,,0,0,09000064804501cb
FDA-2006-E-0125-0005,FDA,FDA-2006-E-0125,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2007-03-08T05:00:00Z,2007,3,,,2026-01-14T19:47:31Z,,0,0,09000064804501ca
FDA-2006-E-0125-0004,FDA,FDA-2006-E-0125,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-01-26T05:00:00Z,2007,1,,,2026-01-06T19:20:14Z,,0,0,09000064804501c9
FDA-2006-E-0125-0003,FDA,FDA-2006-E-0125,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-01-26T05:00:00Z,2007,1,,,2026-01-06T19:16:34Z,,0,0,09000064804501c8